A ‘danse macabre’: tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
A lzheimer's disease, with its two most prominent pathological factors amyloid beta and tau protein, can be described as a disease of the synapse. It therefore comes as little surprise that NMDA receptor‐related synaptic dysfunction had been thought for several years to underlie the synaptic pathophysiology seen in A lzheimer's disease. In this review I will summarise recent evidence showing that the NMDA receptor links the effects of extracellular amyloid beta with intracellular tau protein. Furthermore, the antagonistic roles of F yn and STEP in NMDA receptor regulation, synaptic plasticity and induction of synaptic depression will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 2×
“In more general terms, concerning synaptic plasticity, Αb has been shown to impair hippocampal LTP induction (Lesne et al., 2006) as well as to cause a LTD-like synaptic depression (Hsieh et al., 2006; Shankar et al., 2007; Li et al., 2009).”
BackgroundRetractedReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“They showed that the reduction in tau in heterozygous tau-deficient mice was sufficient to rescue the effects of Αb seen on learning and memory performance in a Morris water maze test (Roberson et al., 2007, 2011).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 5×
“scaffolding protein PSD95 have been shown to form a complex (Ittner et al., 2010; Mondragon-Rodriguez et al., 2012).”
BackgroundInfluentialAPP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Inhibiting the NMDA receptor with the antagonist APV completely blocks the synaptic depression caused by viral expression of APP, which gives rise to Αb (Kamenetz et al., 2003).”
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 3×
“In more general terms, concerning synaptic plasticity, Αb has been shown to impair hippocampal LTP induction (Lesne et al., 2006) as well as to cause a LTD-like synaptic depression (Hsieh et al., 2006; Shankar et al., 2007; Li et al., 2009).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 3×
“STEP is a brain-specific tyrosine phosphatase that regulates synaptic plasticity by dephosphorylating different targets, including the Y1472 of the NMDA receptor subunit GluN2B, Fyn kinase and AMPA receptors (Nguyen et al., 2002; Pelkey et al., 2002; Snyder et al., 2005; Zhang et al., 2008).”
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · cited 1×
“Histological studies of AD patients’ brains have revealed intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein and extracellular amyloid plaques containing the peptide amyloid beta (Αb) (Grundke-Iqbal et al., 1986; Lue et al., 1999; Ingelsson et al., 2004).”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · cited 1×
“…came as a surprise when Hsia and colleagues showed, in a transgenic AD mouse model expressing a mutated form of human APP linked to hereditary cases of AD (APP V717F), that a decrease in synaptic transmission occurred several months prior to neuronal death (Murrell et al., 1991; Hsia et al., 1999).”
Background
Cited by
Rodent models for Alzheimer disease
Götz, J., Bodea, L.-G., & Goedert, M. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0054-8 · Cited by 394
Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235
Dendritic Spine Pathology in Neurodegenerative Diseases
Herms, J., & Dorostkar, M. M. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044216 · Cited by 201
Connecting the dots between tau dysfunction and neurodegeneration
Frost, B., Götz, J., & Feany, M. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.005 · Cited by 124
“A time- resolved model for how Aβ, via Fyn, ultimately causes neuronal demise, posits that Aβ in a first step activates Fyn causing downstream excitotoxicity, and that Aβ later in disease activates STEP, a Fyn-phosphatase that eventually inactivates Fyn, leading to the loss of synapses [23].”
BackgroundLi, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Tau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, L., Eckert, A., Ittner, L. M., Piguet, O., & Götz, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13600 · Cited by 104
“In this context, a recent review discusses the possibility of sequential activation of Fyn, followed by its inactivating phosphatase, striatal-enriched protein tyrosine phosphatase, in the regulation of the NMDA receptor, synaptic plasticity and the induction of synaptic depression, suggesting hyperfunction followed b…”
Background
Metadata
- Authors
- Boehm, J.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2013-06
- Volume
- 37
- Issue
- 12
- Pages
- 1925-1930
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1992818957
- Cited by
- 39
- References
- 32
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.